144 related articles for article (PubMed ID: 34273660)
41. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
42. CD160 serves as a negative regulator of NKT cells in acute hepatic injury.
Kim TJ; Park G; Kim J; Lim SA; Kim J; Im K; Shin MH; Fu YX; Del Rio ML; Rodriguez-Barbosa JI; Yee C; Suh KS; Kim SJ; Ha SJ; Lee KM
Nat Commun; 2019 Jul; 10(1):3258. PubMed ID: 31332204
[TBL] [Abstract][Full Text] [Related]
43. CD160 Stimulates CD8
Tan CL; Peluso MJ; Drijvers JM; Mera CM; Grande SM; Brown KE; Godec J; Freeman GJ; Sharpe AH
Immunohorizons; 2018 Aug; 2(7):238-250. PubMed ID: 31022694
[TBL] [Abstract][Full Text] [Related]
44. Increased CD160 expression on circulating natural killer cells in atherogenesis.
Zuo J; Shan Z; Zhou L; Yu J; Liu X; Gao Y
J Transl Med; 2015 Jun; 13():188. PubMed ID: 26071079
[TBL] [Abstract][Full Text] [Related]
45. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
[TBL] [Abstract][Full Text] [Related]
46. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.
Rodriguez-Barbosa JI; Schneider P; Weigert A; Lee KM; Kim TJ; Perez-Simon JA; Del Rio ML
Cell Mol Immunol; 2019 Jul; 16(7):679-682. PubMed ID: 31160757
[No Abstract] [Full Text] [Related]
47. Expanded antigen-experienced CD160
Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
[TBL] [Abstract][Full Text] [Related]
48. A structural model of the immune checkpoint CD160-HVEM complex derived from HDX-mass spectrometry and molecular modeling.
Kuncewicz K; Spodzieja M; Sieradzan A; Karczyńska A; Dąbrowska K; Dadlez M; Speiser DE; Derre L; Rodziewicz-Motowidło S
Oncotarget; 2019 Jan; 10(4):536-550. PubMed ID: 30728903
[TBL] [Abstract][Full Text] [Related]
49. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.
Nikolova M; Marie-Cardine A; Boumsell L; Bensussan A
Int Immunol; 2002 May; 14(5):445-51. PubMed ID: 11978774
[TBL] [Abstract][Full Text] [Related]
50. Engagement of the CD160 activating NK cell receptor leads to its association with CD2 in circulating human NK cells.
Rabot M; Bensussan A; Le Bouteiller P
Transpl Immunol; 2006 Dec; 17(1):36-8. PubMed ID: 17157212
[TBL] [Abstract][Full Text] [Related]
51. Identification of a human intestinal myeloid cell subset that regulates gut homeostasis.
Barman S; Kayama H; Okuzaki D; Ogino T; Osawa H; Matsuno H; Mizushima T; Mori M; Nishimura J; Takeda K
Int Immunol; 2016 Nov; 28(11):533-545. PubMed ID: 27421871
[TBL] [Abstract][Full Text] [Related]
52. [A Preliminary Study on the Expression of CD160 on NK Cells and Its Mechanism of Mediating NK Killing Effect].
Wang ZH; Liu HH; Ma N; Wang LH; Liu W; Tang B; Qiu ZX; Cen XN; Ren HY; Dong YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1559-1564. PubMed ID: 30295284
[TBL] [Abstract][Full Text] [Related]
53. The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.
Gauci ML; Giustiniani J; Lepelletier C; Garbar C; Thonnart N; Dumaz N; Foussat A; Lebbé C; Bensussan A; Marie-Cardine A
Cancer Immunol Immunother; 2022 Nov; 71(11):2731-2742. PubMed ID: 35428910
[TBL] [Abstract][Full Text] [Related]
54. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
55. CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.
Liu FT; Giustiniani J; Farren T; Jia L; Bensussan A; Gribben JG; Agrawal SG
Blood; 2010 Apr; 115(15):3079-88. PubMed ID: 20164468
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice.
Sadighi Akha AA; McDermott AJ; Theriot CM; Carlson PE; Frank CR; McDonald RA; Falkowski NR; Bergin IL; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):587-97. PubMed ID: 25327211
[TBL] [Abstract][Full Text] [Related]
57. Increased Heterologous Protein Expression in Drosophila S2 Cells for Massive Production of Immune Ligands/Receptors and Structural Analysis of Human HVEM.
Liu W; Vigdorovich V; Zhan C; Patskovsky Y; Bonanno JB; Nathenson SG; Almo SC
Mol Biotechnol; 2015 Oct; 57(10):914-22. PubMed ID: 26202493
[TBL] [Abstract][Full Text] [Related]
58. Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases.
He W; Wang B; Li Q; Yao Q; Jia X; Song R; Li S; Zhang JA
Front Immunol; 2019; 10():261. PubMed ID: 30842773
[TBL] [Abstract][Full Text] [Related]
59. High Levels of CD244 Rather Than CD160 Associate With CD8
Wang X; Wang D; Du J; Wei Y; Song R; Wang B; Qiu S; Li B; Zhang L; Zeng Y; Zhao H; Kong Y
Front Immunol; 2022; 13():853522. PubMed ID: 35386693
[TBL] [Abstract][Full Text] [Related]
60. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
